Lockdown measures in response to COVID-19 in nine sub-Saharan African countries.


Journal

BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275

Informations de publication

Date de publication:
10 2020
Historique:
received: 01 07 2020
revised: 09 09 2020
accepted: 11 09 2020
entrez: 8 10 2020
pubmed: 9 10 2020
medline: 27 10 2020
Statut: ppublish

Résumé

Lockdown measures have been introduced worldwide to contain the transmission of COVID-19. However, the term 'lockdown' is not well-defined. Indeed, WHO's reference to 'so-called lockdown measures' indicates the absence of a clear and universally accepted definition of the term 'lockdown'. We propose a definition of 'lockdown' based on a two-by-two matrix that categorises different communicable disease measures based on whether they are compulsory or voluntary; and whether they are targeted at identifiable individuals or facilities, or whether they are applied indiscriminately to a general population or area. Using this definition, we describe the design, timing and implementation of lockdown measures in nine countries in sub-Saharan Africa: Ghana, Nigeria, South Africa, Sierra Leone, Sudan, Tanzania, Uganda, Zambia and Zimbabwe. While there were some commonalities in the implementation of lockdown across these countries, a more notable finding was the variation in the design, timing and implementation of lockdown measures. We also found that the number of reported cases is heavily dependent on the number of tests carried out, and that testing rates ranged from 2031 to 63 928 per million population up until 7 September 2020. The reported number of COVID-19 deaths per million population also varies (0.4 to 250 up until 7 September 2020), but is generally low when compared with countries in Europe and North America. While lockdown measures may have helped inhibit community transmission, the pattern and nature of the epidemic remains unclear. However, there are signs of lockdown harming health by affecting the functioning of the health system and causing social and economic disruption.

Identifiants

pubmed: 33028699
pii: bmjgh-2020-003319
doi: 10.1136/bmjgh-2020-003319
pmc: PMC7542624
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Wellcome Trust
ID : 206316/Z/17/Z
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

J Microbiol Immunol Infect. 2020 Jun;53(3):467-472
pubmed: 32299783
Epidemiol Infect. 2020 Feb 26;148:e41
pubmed: 32100667
Lancet Infect Dis. 2020 May;20(5):546
pubmed: 32311326
Epidemiol Infect. 2020 Jun 09;148:e113
pubmed: 32513346
J Travel Med. 2020 May 18;27(3):
pubmed: 32181488
Lancet. 2020 Mar 14;395(10227):912-920
pubmed: 32112714
Int J Infect Dis. 2020 Jul;96:308-310
pubmed: 32437938
Am J Trop Med Hyg. 2020 Aug;103(2):564-569
pubmed: 32484156

Auteurs

Najmul Haider (N)

Pathobiology and Population Science, The Royal Veterinary College, London, UK.

Abdinasir Yusuf Osman (AY)

Pathobiology and Population Science, The Royal Veterinary College, London, UK.

Audrey Gadzekpo (A)

Department of Communication Studies, University of Ghana, Legon, Ghana.

George O Akipede (GO)

College of Medicine, Ambrose Alli University, Ekpoma, Nigeria and Institute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Nigeria.

Danny Asogun (D)

Community Medicine, Irrua Specialist Teaching Hospital, Irrua, Edo, Nigeria.

Rashid Ansumana (R)

Mercy Hospital Research Laboratory, Freetown, Sierra Leone.

Richard John Lessells (RJ)

Department of Pubic Health, University of KwaZulu-Natal, Durban, South Africa.

Palwasha Khan (P)

Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.

Muzamil Mahdi Abdel Hamid (MMA)

Department of Parasitology and Medical Entomology, Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan.

Dorothy Yeboah-Manu (D)

Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.

Leonard Mboera (L)

SACIDS Foundation for One Health, Sokoine University of Agricultue, Morogoro, Tanzania.

Elizabeth Henry Shayo (EH)

Department of Policy Analysis and Advocacy, National Institute for Medical Research, Dar es Salaam, Tanzania.

Blandina T Mmbaga (BT)

Department of Paediatrics, Kilimanjaro Christian Medical University College, Moshi, Tanzania.
Kilimanjaro Clinical Research Institute, Moshi, Tanzania.

Mark Urassa (M)

National Institute for Medical Research Mwanza Research Centre, Mwanza, Tanzania.

David Musoke (D)

School of Public Health, Makerere University College of Health Sciences, Kampala, Uganda.

Nathan Kapata (N)

Ministry of Health, Lusaka, Zambia.

Rashida Abbas Ferrand (RA)

Biomedical Research and Training Institute, Harare, Zimbabwe.
Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK.

Pascalina-Chanda Kapata (PC)

Ministry of Health, Lusaka, Zambia.

Florian Stigler (F)

Austrian Sickness Fund, Vienna, Austria.

Thomas Czypionka (T)

Health Economics and Health Policy, Institute for Advanced Studies, Vienna, Austria.
Health Policy, London School of Economics and Political Science, London, UK.

Alimuddin Zumla (A)

Centre for Clinical Microbiology, University College London, London, UK.

Richard Kock (R)

Pathobiology and Population Science, The Royal Veterinary College, London, UK.

David McCoy (D)

Institute of Population Health Sciences, Barts and London Medical and Dental School, Queen Mary University of London, London, UK d.mccoy@qmul.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH